Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dipraglurant is a negative allosteric regulator (NAM) of blood-brain barrier transmissible mGluR5 with effective, selective and oral activity, with an IC50 value of 21 nM. Dipraglurant can treat levodopa-induced dyskinesia in Parkinson's disease (PD-LID).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 269.00 | |
25 mg | 6-8 weeks | $ 1,260.00 | |
50 mg | 6-8 weeks | $ 1,640.00 | |
100 mg | 6-8 weeks | $ 2,500.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 396.00 |
Description | Dipraglurant is a negative allosteric regulator (NAM) of blood-brain barrier transmissible mGluR5 with effective, selective and oral activity, with an IC50 value of 21 nM. Dipraglurant can treat levodopa-induced dyskinesia in Parkinson's disease (PD-LID). |
Targets&IC50 | mGluR5:21 nM (IC50) |
Synonyms | ADX48621 |
Molecular Weight | 265.29 |
Formula | C16H12FN3 |
CAS No. | 872363-17-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (150.78 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dipraglurant 872363-17-2 Others ADX 48621 ADX48621 ADX-48621 inhibitor inhibit